Silo Pharma Enters into Sponsored Research Agreement for Potential Multiple Sclerosis Treatment Approach with University of Maryland, Baltimore
Silo Pharma could Utilize Data for Psilocybin Delivery potential to Central Nervous System Englewood Cliffs, NJ, Jan. 13, 2021 (GLOBE
Read more